Immunomodulation: a new role for statins?
Palinski
W
W
D000276:Adjuvants, Immunologic; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001158:Arteries / Q000276:immunology; D001161:Arteriosclerosis / Q000276:immunology*; D002784:Cholesterol / Q000096:biosynthesis; D005786:Gene Expression Regulation / Q000187:drug effects; D005802:Genes, MHC Class II; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008798:Mevalonic Acid / Q000494:pharmacology; D018448:Models, Immunological; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000924:Anticholesteremic Agents; D000949:Histocompatibility Antigens Class II; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D008798:Mevalonic Acid